EP3490893A1 - Opening assembly for bags housing containers for pharmaceutical use - Google Patents

Opening assembly for bags housing containers for pharmaceutical use

Info

Publication number
EP3490893A1
EP3490893A1 EP17743339.8A EP17743339A EP3490893A1 EP 3490893 A1 EP3490893 A1 EP 3490893A1 EP 17743339 A EP17743339 A EP 17743339A EP 3490893 A1 EP3490893 A1 EP 3490893A1
Authority
EP
European Patent Office
Prior art keywords
bag
clamping mechanism
opening assembly
zone
clamping
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP17743339.8A
Other languages
German (de)
French (fr)
Other versions
EP3490893B2 (en
EP3490893B1 (en
Inventor
Claudio Trebbi
Gabriele Gabusi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMA Industria Macchine Automatiche SpA
Original Assignee
IMA Industria Macchine Automatiche SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57610180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP3490893(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by IMA Industria Macchine Automatiche SpA filed Critical IMA Industria Macchine Automatiche SpA
Publication of EP3490893A1 publication Critical patent/EP3490893A1/en
Application granted granted Critical
Publication of EP3490893B1 publication Critical patent/EP3490893B1/en
Publication of EP3490893B2 publication Critical patent/EP3490893B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B69/00—Unpacking of articles or materials, not otherwise provided for
    • B65B69/0008—Opening and emptying bags
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B69/00—Unpacking of articles or materials, not otherwise provided for
    • B65B69/0033—Unpacking of articles or materials, not otherwise provided for by cutting
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B69/00—Unpacking of articles or materials, not otherwise provided for
    • B65B69/005—Unpacking of articles or materials, not otherwise provided for by expelling contents, e.g. by squeezing the container
    • B65B69/0058—Solid contents

Definitions

  • the present invention relates to an opening assembly for bags housing containers for pharmaceutical use.
  • the bag of specific interest is intended for containment and segregation with respect to the outside environment of containers such as vials, bottles, syringes, carpules and the like.
  • the nest is, in turn, placed inside a sterile tub with a protective film on top which has the purpose of preventing entrance into the containers (which have an upper opening open towards the outside) of dust or other particles.
  • the upper edges of the tub (containing protective film, nest and containers) are permanently joined to a sealing film in order to completely isolate the inside of the tub from the outside.
  • the sealed tub is placed within a bag (generally made of polymeric material) which constitutes a second protective barrier (since the outside of the tub and the sealing film must in any case be sterile).
  • a bag generally made of polymeric material which constitutes a second protective barrier (since the outside of the tub and the sealing film must in any case be sterile).
  • bag opening operations are such as to give rise to a risk of contamination (during the cutting step, particles may in fact detach and enter inside the bag, coming into contact with the protective film or the outside of the tub) .
  • the presence of particles on the protective film and/or the outer surface of the tub is particularly risky because removal of the film generally occurs when the tub is already in the environment with the highest contamination class (i.e., ISO 5 Class or lower, thus, with the least presence of contaminants) and could cause the diffusion of such particles (deposited on the film and/or tub) in that environment.
  • DE 10 2011 080289 discloses a device for opening a bag according to the prior art.
  • the main aim of the present invention is to solve the problems outlined above, by proposing an opening assembly for bags housing containers for pharmaceutical use capable of cutting the outer bag while preventing particles, in suspension and/or generated during the cutting step, from entering inside the bag.
  • an object of the invention is to propose an opening assembly for bags housing containers for pharmaceutical use that ensures isolation of the bag's content with respect to the outside environment even after opening the bag.
  • Another object of the invention is to propose an opening assembly for packaging of containers for pharmaceutical use capable of guaranteeing sterility of the containers transported in the nest present inside the tub, sealed by a protective film, and segregated inside the bag.
  • Figure 1 shows, in a schematic axonometric view, a portion of an opening assembly for bags housing containers for pharmaceutical use according to the invention
  • Figure 2 shows, in a schematic side view, the opening assembly for bags housing containers for pharmaceutical use according to the invention
  • an opening assembly for bags B housing containers A for pharmaceutical use.
  • the bag B is generally hermetically sealed and preferably made of polymeric material.
  • the assembly 1 comprises at least one clamping mechanism 2 to clamp a portion C of the bag B spaced apart (inwardly) with respect to an end flap D of the bag.
  • the clamping mechanism 2 is arranged so as to clamp together sections of opposing sheets E, F of the bag B.
  • the assembly 1 further comprises at least one cutting element 2a for the trimming of the end flap D with respect to the portion C defined by the sections of opposing sheets E, F of the bag B mutually clamped together by the clamping mechanism 2.
  • the bag B is in fact already opened (because it is without the end flap D) and thus subsequent access to its contents will not require any operation capable of generating contaminants and/or particles (which may in fact detach during the cutting step) thereby greatly improving the sterility and cleanliness of containers A transported inside the bag B.
  • the opening assembly further comprises gripping mechanisms 14 equipped with at least one clamping jaw
  • the cutting element 2a is designed to separate the end flap D and is arranged between the gripping mechanisms 14 and the clamping mechanism 2.
  • these gripping mechanisms 14 are associated with a transport device 5.
  • the transport device 5 in the illustrated example comprises a proximal section 10 arranged in a first zone 9 and a distal section 12 arranged in a second zone 11, wherein the first zone 9 has a higher contamination class and a higher ambient pressure than the second zone.
  • Said transport device 5 may be a closed loop design and driven by an automatic motor drive unit connected to a control and management processor.
  • the clamping mechanism 2 is integral with a moveable terminal end 3 of a manipulator 4.
  • manipulator 4 can advantageously move between at least two end configurations.
  • a first configuration whereby the bag B is removed from the transport device 5 for the clamping of said opposing sheets E, F with the clamping mechanism 2; and a second alignment configuration whereby the bag B is brought in proximity to an opening 6 defined on a separation wall 7 separating the first zone 9 from a compartment 8 with a higher contamination class and higher ambient pressure compared to the first zone 9.
  • the first zone 9 within which the manipulator 4 operates and in which the proximal section 10 of the transport device 5 is located has a higher contamination class and a higher ambient pressure compared to the second zone 11 in which the distal section 12 of the transport device 5 is located.
  • an operating condition will occur whereby the transport of packaging A will be carried out in ambient conditions with a less stringent contamination class (i.e, ISO Class 6 or ISO Class 7), the cutting of the end flap D and thus the opening of the bag B will occur in ambient conditions with an intermediate contamination class (according to the previous example, in ISO Class 6 or ISO Class 6+ or ISO Class 5 respectively), while the extraction of the contents of the bag B will only occur in the compartment 8 in which there is a higher contamination class (according to the previous example, ISO Class 5).
  • a less stringent contamination class i.e, ISO Class 6 or ISO Class 7
  • an intermediate contamination class accordinging to the previous example, in ISO Class 6 or ISO Class 6+ or ISO Class 5 respectively
  • the manipulator 4 can be an anthropomorphic-type robot.
  • the first zone 9 there is preferably arranged at least one dispenser of a gas flow intended to flow over the proximal section 10 of the transport device 5, the bag B transported along the end section 10 and the manipulator 4.
  • Such gas flow will provide the necessary overpressure in the first zone 9, with respect to the second zone 11 in which the distal section 12 of the transport device 5 is located so as to prevent access to the first zone 9 of particles and/or contaminants present in suspension in the air in the second zone 11.
  • the gas flow present in the first zone 9 will be of the laminar type.
  • the gas relating to such flow may be air (other types of gas such as inert gas, nitrogen and the like are not excluded).
  • the transport device 5 thus adopted allows all surfaces of each bag B to be invested by the gas, favoring the detachment of any particles accumulated thereupon, while hindering the deposit of any other particles present in suspension in the air of the particular environment in question.
  • a portion C of the bag B spaced apart (inwardly) relative to an end flap D, in alignment with a clamping mechanism 2.
  • a final step of the process involves trimming by means of a cutting element 2a the end flap D with respect to the portion C corresponding to the sections of opposing sheets E, F of the bag B mutually clamped together by the clamping mechanism 2.
  • the process involves aligning the portion C of bag B to the clamping mechanism 2, keeping it sealed by isolating the contents of the bag B from the outside environment, at a subsequent operating station, so that the containers A placed inside the bag B remain isolated from the outside environment even after the trimming.
  • the present invention solves the problems outlined above, by proposing an opening assembly 1 for bags housing containers for pharmaceutical use, preventing particles, in suspension and/or generated during the cutting step, from entering inside the bag B.
  • the opening assembly 1 guarantees the isolation of the contents of the bag B from the outside environment even after cutting the bag B.
  • the opening assembly 1 according to the invention is capable of guaranteeing the sterility of the containers transported in the nest inside the tub, sealed by a protective film, and segregated inside the bag B.
  • the opening assembly 1 according to the invention is relatively simple and practical to implement, and also entails contained costs: these features make the unit 1 an innovative and safe application.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Bag Frames (AREA)
  • Packages (AREA)

Abstract

Opening assembly for bags (B) housing containers (A) for pharmaceutical use, comprising at least one clamping mechanism (2) for clamping a portion (C) of said bag (B) spaced apart with respect to an end flap (D) of the bag, said clamping mechanism (2) arranged so as to clamp together sections of opposing sheets (E, F) of said bag (B), and at least one cutting element (2a) for the trimming and the separation of said end flap (D) with respect to said sections of said opposing sheets (E, F) of said bag (B) mutually clamped together by said clamping mechanism (2).

Description

OPENING ASSEMBLY FOR BAGS HOUSING CONTAINERS FOR PHARMACEUTICAL USE
The present invention relates to an opening assembly for bags housing containers for pharmaceutical use.
The bag of specific interest is intended for containment and segregation with respect to the outside environment of containers such as vials, bottles, syringes, carpules and the like.
These containers undergo washing and sterilization treatments to ensure that there is no residue inside them (not even dust particles and the like) and to remove any contaminants from their surfaces.
These containers are also normally collected in a nest, which also undergoes similar washing and sterilization treatments.
The nest is, in turn, placed inside a sterile tub with a protective film on top which has the purpose of preventing entrance into the containers (which have an upper opening open towards the outside) of dust or other particles. The upper edges of the tub (containing protective film, nest and containers) are permanently joined to a sealing film in order to completely isolate the inside of the tub from the outside.
The sealed tub is placed within a bag (generally made of polymeric material) which constitutes a second protective barrier (since the outside of the tub and the sealing film must in any case be sterile).
In this way it is possible to transport the containers so packaged with the guarantee that they will not be subject to involuntary contamination.
Once at the factory where the containers will be filled with specific substances of various types, they will need to be handled in order to be transported first to the station at which the bag will be opened, and then to the station where the opening film will be removed and finally the filling station for each single container.
These operations will be performed in environments that present a specific particle contamination class (filling operations will be performed in the environment with a lower risk of contamination).
Environments and products are identified by contamination classes defined according to ISO14644/1: the highest contamination class (therefore relating to the environment in which the smallest particle size corresponds at least to that defined as "ISO Class 5" (thus, it could also be an ISO Class 4, 3, 2, 1). Bag opening operations should be carried out in an environment with a lower risk of contamination compared to the one in which the bags are transported, while the protective film may be removed from the tub only in the environment with the least risk of contamination (i.e., in an environment with ISO contamination class of 5 or lower), imposing additional constraints on the step when removal of the protective film is carried out. It is specified that the atmosphere inside the bag will also present a very low contamination class (such as, an ISO Class less than or equal to 5). In any event, bag opening operations are such as to give rise to a risk of contamination (during the cutting step, particles may in fact detach and enter inside the bag, coming into contact with the protective film or the outside of the tub) . The presence of particles on the protective film and/or the outer surface of the tub is particularly risky because removal of the film generally occurs when the tub is already in the environment with the highest contamination class (i.e., ISO 5 Class or lower, thus, with the least presence of contaminants) and could cause the diffusion of such particles (deposited on the film and/or tub) in that environment.
DE 10 2011 080289 discloses a device for opening a bag according to the prior art.
The main aim of the present invention is to solve the problems outlined above, by proposing an opening assembly for bags housing containers for pharmaceutical use capable of cutting the outer bag while preventing particles, in suspension and/or generated during the cutting step, from entering inside the bag.
Within the scope of this aim, an object of the invention is to propose an opening assembly for bags housing containers for pharmaceutical use that ensures isolation of the bag's content with respect to the outside environment even after opening the bag.
Another object of the invention is to propose an opening assembly for packaging of containers for pharmaceutical use capable of guaranteeing sterility of the containers transported in the nest present inside the tub, sealed by a protective film, and segregated inside the bag.
It is a further object of this invention to provide an opening assembly for bags housing containers for pharmaceutical use at a low cost and relatively simple, practical implementation and safe application.
This aim and these objects are achieved by an opening assembly for bags housing containers for pharmaceutical use in accordance with Claim 1. Further characteristics and advantages of the invention will become apparent from the description of a preferred, but not exclusive, embodiment of the opening assembly for bags housing containers according to the invention, illustrated by way of a non-limiting example, in the accompanying drawings, in which:
Figure 1 shows, in a schematic axonometric view, a portion of an opening assembly for bags housing containers for pharmaceutical use according to the invention;
Figure 2 shows, in a schematic side view, the opening assembly for bags housing containers for pharmaceutical use according to the invention;
With particular reference to the aforementioned figures, it is generally indicated with 1 an opening assembly for bags B housing containers A for pharmaceutical use.
The bag B is generally hermetically sealed and preferably made of polymeric material.
The assembly 1 comprises at least one clamping mechanism 2 to clamp a portion C of the bag B spaced apart (inwardly) with respect to an end flap D of the bag.
The clamping mechanism 2 is arranged so as to clamp together sections of opposing sheets E, F of the bag B.
The assembly 1 further comprises at least one cutting element 2a for the trimming of the end flap D with respect to the portion C defined by the sections of opposing sheets E, F of the bag B mutually clamped together by the clamping mechanism 2.
In this way, it is possible to ensure the clamping of sheets E and F (in particular the portion C on which the clamping mechanism 2 acts) such as to completely segregate and seal the inside of the bag B with respect to the outside environment. After this step is performed (which ensures that no contamination of the contents of the bag B can occur), the end flap D of the bag B (thus, the opening of the bag B) can then be removed. The transfer to subsequent operating stations where it may be necessary to access the contents of the bag B will occur while the sections of opposing sheets E and F (portion C) are clamped together sealed by the clamping mechanism 2 and thus under such conditions as to prevent contamination of the contents of the bag B. However, during this transfer, the bag B is in fact already opened (because it is without the end flap D) and thus subsequent access to its contents will not require any operation capable of generating contaminants and/or particles (which may in fact detach during the cutting step) thereby greatly improving the sterility and cleanliness of containers A transported inside the bag B.
In accordance with the present invention, the opening assembly further comprises gripping mechanisms 14 equipped with at least one clamping jaw
15 for gripping the end flap D of the bag B when the bag B hangs from the at least one said jaw 15 of the gripping mechanism 14.
This arrangement is extremely advantageous as it ensures that no undesirable particle buildup can occur on any of the outer surfaces of the bag B: in the traditional type handling units, the bags B lie onto a conveyor belt. The surface of the conveyor belt faces a laminar air flow, but it is not possible to exclude the deposit of particles on the same.
In any case, when the bags B lie on the conveyor belt's surface, the side of the bag B in contact with the conveyor belt is not exposed to the flow and therefore any accumulations of particles (present on the side of the bag B or on the conveyor belt) will not be affected by the flow which will thus not remove them.
Advantageously, the cutting element 2a is designed to separate the end flap D and is arranged between the gripping mechanisms 14 and the clamping mechanism 2.
Preferably, these gripping mechanisms 14 are associated with a transport device 5.
The transport device 5 in the illustrated example comprises a proximal section 10 arranged in a first zone 9 and a distal section 12 arranged in a second zone 11, wherein the first zone 9 has a higher contamination class and a higher ambient pressure than the second zone.
Said transport device 5 may be a closed loop design and driven by an automatic motor drive unit connected to a control and management processor.
In accordance with a preferred embodiment of the present invention, the clamping mechanism 2 is integral with a moveable terminal end 3 of a manipulator 4.
In this way, after clamping the portion C with the clamping mechanism 2 and removing the end flap D with the cutting element 2a, it is possible to remove the bag B (and its contents isolated from the outside environment) from the transport device 5 through the manipulator 4, maintaining the sections of opposing sheets E, F mutually clamped together by means of the clamping mechanism 2, and deliver them to a possible downstream operating station.
It is considered useful to specify that the manipulator 4 can advantageously move between at least two end configurations.
A first configuration whereby the bag B is removed from the transport device 5 for the clamping of said opposing sheets E, F with the clamping mechanism 2; and a second alignment configuration whereby the bag B is brought in proximity to an opening 6 defined on a separation wall 7 separating the first zone 9 from a compartment 8 with a higher contamination class and higher ambient pressure compared to the first zone 9.
By way of example, it is specified that inside the compartment 8, an ISO contamination class of "5" or lower, more "safe" compared to the one in the first zone 9, could be established.
With particular reference to an embodiment capable of meeting the stringent regulatory requirements in force concerning the packaging of drugs and even define improved safety standards in connection with the same, the first zone 9 within which the manipulator 4 operates and in which the proximal section 10 of the transport device 5 is located, has a higher contamination class and a higher ambient pressure compared to the second zone 11 in which the distal section 12 of the transport device 5 is located. In practice, an operating condition will occur whereby the transport of packaging A will be carried out in ambient conditions with a less stringent contamination class (i.e, ISO Class 6 or ISO Class 7), the cutting of the end flap D and thus the opening of the bag B will occur in ambient conditions with an intermediate contamination class (according to the previous example, in ISO Class 6 or ISO Class 6+ or ISO Class 5 respectively), while the extraction of the contents of the bag B will only occur in the compartment 8 in which there is a higher contamination class (according to the previous example, ISO Class 5).
According to a particularly efficient and easily programmable version, the manipulator 4 can be an anthropomorphic-type robot.
In the first zone 9, there is preferably arranged at least one dispenser of a gas flow intended to flow over the proximal section 10 of the transport device 5, the bag B transported along the end section 10 and the manipulator 4.
Such gas flow will provide the necessary overpressure in the first zone 9, with respect to the second zone 11 in which the distal section 12 of the transport device 5 is located so as to prevent access to the first zone 9 of particles and/or contaminants present in suspension in the air in the second zone 11.
It is specified that, preferably, the gas flow present in the first zone 9 will be of the laminar type.
With reference to an embodiment that is simple to implement, it should be noted that the gas relating to such flow may be air (other types of gas such as inert gas, nitrogen and the like are not excluded).
The transport device 5 thus adopted allows all surfaces of each bag B to be invested by the gas, favoring the detachment of any particles accumulated thereupon, while hindering the deposit of any other particles present in suspension in the air of the particular environment in question.
The operation of the present invention is precisely outlined in the steps listed below.
In a first step, it is necessary to have a portion C of the bag B, spaced apart (inwardly) relative to an end flap D, in alignment with a clamping mechanism 2.
Subsequently, in a second step, it will be necessary to clamp, with the clamping mechanism 2, sections of opposing sheets E, F of the bag B, that is, the portion C, isolating the contents of the part of bag B that is downstream with respect to the clamping mechanism 2.
A final step of the process involves trimming by means of a cutting element 2a the end flap D with respect to the portion C corresponding to the sections of opposing sheets E, F of the bag B mutually clamped together by the clamping mechanism 2.
Preferably, the process involves aligning the portion C of bag B to the clamping mechanism 2, keeping it sealed by isolating the contents of the bag B from the outside environment, at a subsequent operating station, so that the containers A placed inside the bag B remain isolated from the outside environment even after the trimming.
Advantageously, the present invention solves the problems outlined above, by proposing an opening assembly 1 for bags housing containers for pharmaceutical use, preventing particles, in suspension and/or generated during the cutting step, from entering inside the bag B.
Effectively, the opening assembly 1 according to the invention guarantees the isolation of the contents of the bag B from the outside environment even after cutting the bag B.
Appropriately, the opening assembly 1 according to the invention is capable of guaranteeing the sterility of the containers transported in the nest inside the tub, sealed by a protective film, and segregated inside the bag B. Beneficially, the opening assembly 1 according to the invention is relatively simple and practical to implement, and also entails contained costs: these features make the unit 1 an innovative and safe application.
The invention, thus conceived, is susceptible to numerous modifications and variants all falling within the scope of the inventive concept; moreover, all of the details may be replaced by other technically equivalent elements. In the sample embodiments illustrated, individual features, described in relation to specific examples, are in fact interchangeable with other different features, existing in other embodiments.
In practice, the materials used, as well as their sizes, may be of any kind according to the requirements and the state of the art.

Claims

1. Opening assembly for bags (B) housing containers (A) for pharmaceutical use, comprising at least one clamping mechanism (2) for clamping a portion (C) of said bag (B) and at least one cutting element (2a) characterized in that said clamping mechanism (2) is arranged to clamp together sections of opposing sheets (E, F) of said bag (B) which are spaced apart with respect to an end flap (D) of the bag (B) and in that said at least one cutting element (2a) is arranged and configured for the trimming and the separation of said end flap (D) protruding with respect to said sections of said opposing sheets (E, F) of said bag (B) mutually clamped together by said clamping mechanism (2).
2. Opening assembly according to Claim 1, comprising gripping mechanisms (14) equipped with at least one clamping jaw (15) for gripping said end flap (D) of the bag (B), said bag (B) hanging from the at least one jaw (15) of the gripping mechanism (14).
3. Opening assembly, according to Claim 2, wherein said gripping mechanisms (14) are associated to a transport device (5).
4. Opening assembly according to Claim 3, wherein said transport device (5) comprises a proximal section (10) arranged in a first zone (9) and a distal section (12) arranged in a second zone (11), wherein the first zone (9) has a higher contamination class and a higher ambient pressure than the second zone (11).
5. Opening assembly according to Claim 3 or 4, wherein said transport device (5) has a closed loop configuration and is driven by an automatic drive unit connected to a control and management processor.
6. Opening assembly according to any one of the preceding Claims 2 to 5, wherein said cutting element (2a) is arranged between said gripping mechanisms (14) and said clamping mechanism (2), when the end flap (D) is separated from said sections of opposing sheets (E, F) clamped by the
5 clamping mechanism (2).
7. Opening assembly according to any one of the preceding Claims, wherein said clamping mechanism (2) is integral with a movable terminal end (3) of a manipulator (4).
8. Opening assembly according to Claim 7, wherein said manipulator (4) is0 an anthropomorphic-type robot.
9. Opening assembly according to Claim 7 or 8, wherein said manipulator (4) is movable between at least two end configurations, a first configuration wherein the bag (B) is removed from said transport device (5) for the clamping of said opposing sheets (E, F) with said clamping mechanism (2),5 and a second configuration wherein the bag (B) is brought in proximity to an opening (6) defined on a separation wall (7) separating said first zone (9) from a compartment (8) with a higher contamination class and higher ambient pressure compared to the first zone (9).
10. Opening assembly, according to Claim 9, wherein in said first zone (9), o there is arranged at least one dispenser of a gas flow intended to flow over the proximal section (10) of said transport device (5), said bag (B) transported along said end section (10) and said manipulator (4) located in the first zone (9).
11. Opening assembly according to Claim 10, wherein said gas flow is of5 the laminar type.
12. Method for opening bags (B) housing containers (A) for pharmaceutical use, comprising the steps of:
arranging a portion (C) of said bag (B) spaced apart with respect to an end flap (D) in alignment with a clamping mechanism (2);
clamping together sections of opposing sheets (E, F) of said bag (B) with said clamping mechanism (2);
trimming and separating, by means of a cutting element (2a), said end flap (D) with respect to said sections of said opposing sheets (E, F) of said bag (B) mutually clamped together by said clamping mechanism (2).
13. Method according to Claim 12, further comprising the step of aligning the portion of bag (B) clamped by said clamping mechanism (2) at a subsequent operating station.
14. Method according to Claim 12 or 13, wherein the clamping of the bag (B) with the clamping mechanism (2) keeps said sections of opposing sheets (E, F) clamped together, so that the containers (A) placed inside of the bag (B) remain isolated from the outside environment even after trimming.
EP17743339.8A 2016-07-27 2017-07-26 Opening assembly for bags housing containers for pharmaceutical use Active EP3490893B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102016000078609A IT201600078609A1 (en) 2016-07-27 2016-07-27 OPENING GROUP FOR PHARMACEUTICAL CONTAINER PACKAGES
PCT/EP2017/068858 WO2018019874A1 (en) 2016-07-27 2017-07-26 Opening assembly for bags housing containers for pharmaceutical use

Publications (3)

Publication Number Publication Date
EP3490893A1 true EP3490893A1 (en) 2019-06-05
EP3490893B1 EP3490893B1 (en) 2021-03-24
EP3490893B2 EP3490893B2 (en) 2025-09-10

Family

ID=57610180

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17743339.8A Active EP3490893B2 (en) 2016-07-27 2017-07-26 Opening assembly for bags housing containers for pharmaceutical use

Country Status (8)

Country Link
US (1) US20210292032A1 (en)
EP (1) EP3490893B2 (en)
JP (1) JP6971305B2 (en)
CN (1) CN109715505B (en)
CA (1) CA3032037A1 (en)
ES (1) ES2874645T5 (en)
IT (1) IT201600078609A1 (en)
WO (1) WO2018019874A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018210747A1 (en) * 2018-06-29 2020-01-02 Robert Bosch Gmbh Device and method for feeding an object
CN109625500B (en) * 2019-01-25 2020-11-06 格瑞果汁工业（天津）有限公司 Jam pouch bag opening machine
IT201900006552A1 (en) * 2019-05-06 2020-11-06 Ima Spa APPARATUS AND METHOD FOR THE AUTOMATED MANAGEMENT OF A CONTROLLED ATMOSPHERE PROCESSING CHAMBER.
CN111513357A (en) * 2019-12-02 2020-08-11 广州富港万嘉智能科技有限公司 Automatic making and selling equipment for food containing stuffing
US12030688B1 (en) * 2020-08-27 2024-07-09 Express Scripts Strategic Development, Inc. Systems and methods for pharmaceutical container processing
DE102021104221A1 (en) * 2021-02-23 2022-08-25 Syntegon Technology Gmbh Device and method for converting a packaging unit into a barrier system for pharmaceuticals
IT202100004685A1 (en) * 2021-03-01 2022-09-01 Ima Spa PROCEDURE AND APPARATUS FOR THE AUTOMATIC TREATMENT OF ENVELOPES.
GB2606021B (en) * 2021-04-23 2023-07-19 Mpac Group Plc Packaging removal apparatus
DE102022110051A1 (en) * 2022-04-26 2023-10-26 Syntegon Technology Gmbh Device, set, pharmaceutical system and method for unpacking a variety of items
DE102022110826A1 (en) 2022-05-03 2023-11-09 Tt Innovation Ag Device for manipulating bags containing containers
CN115043051B (en) * 2022-05-19 2023-08-04 玉林市第一人民医院 Sealing bag unpacking device and method for novel coronavirus nucleic acid detection specimen
WO2022195572A2 (en) * 2022-05-25 2022-09-22 Indian Institute of Technology Guwahati Sachet/pouch cutting and squeezing apparatus
DE102022118701A1 (en) * 2022-07-26 2024-02-01 Tt Innovation Ag Method for removing a container from a bag, cutting device, removal device and unpacking device

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20060246A1 (en) 2006-04-05 2007-10-06 Ima Spa APPARATUS AND METHOD TO FEED WITH A PRODUCT A PACKAGING MACHINE.
WO2008016313A1 (en) 2006-08-02 2008-02-07 J.M.P. Engineering Limited A multi layer bag separator
CH702317B1 (en) * 2007-08-02 2011-06-15 Stevanato Group Internat As Structure of the pack of glass vials for pharmaceutical use.
CN201228095Y (en) * 2008-05-20 2009-04-29 刘雪 Bag slitting machine
DE202009005086U1 (en) 2009-07-30 2010-12-16 Autefa Automation Gmbh opening device
DE102010039635A1 (en) 2010-08-23 2012-02-23 Robert Bosch Gmbh A method for disposing of sterile packaging material and apparatus therefor
IT1401846B1 (en) 2010-10-14 2013-08-28 Co Ri M A S R L APPARATUS AND METHOD TO REMOVE A STERILE PRODUCT FROM A STERILE PACKAGE THAT CONTAINS IT
DE102010063892B4 (en) 2010-12-22 2023-10-19 Syntegon Technology Gmbh Device and method for removing an object from a packaging
DE102011080289B4 (en) * 2011-08-02 2021-07-08 Syntegon Technology Gmbh Apparatus and method for removing a sterile object from a foil pouch
DE102014201967B4 (en) * 2014-02-04 2024-09-26 Syntegon Technology Gmbh Device and method for removing containers from a tray
DE102014201966B4 (en) 2014-02-04 2024-09-26 Syntegon Technology Gmbh Device and method for handling a tray
JP6413053B2 (en) * 2014-10-29 2018-10-31 ゼネラルパッカー株式会社 Packaging machine
CN206871457U (en) * 2017-07-11 2018-01-12 象山益精高分子材料有限公司 A kind of open the bag device

Also Published As

Publication number Publication date
EP3490893B2 (en) 2025-09-10
IT201600078609A1 (en) 2018-01-27
CN109715505A (en) 2019-05-03
US20210292032A1 (en) 2021-09-23
CA3032037A1 (en) 2018-02-01
JP6971305B2 (en) 2021-11-24
WO2018019874A1 (en) 2018-02-01
ES2874645T5 (en) 2026-01-02
CN109715505B (en) 2021-02-26
ES2874645T3 (en) 2021-11-05
JP2019521927A (en) 2019-08-08
EP3490893B1 (en) 2021-03-24

Similar Documents

Publication Publication Date Title
EP3490893B1 (en) Opening assembly for bags housing containers for pharmaceutical use
JP7030105B2 (en) Removal unit for removing contents from bags in the fields of pharmaceuticals and chemistry
JP6911257B2 (en) Methods and machines for filling and sealing bottles, cartridges, syringes, etc.
CN109789941B (en) Opening components for packaging
CN109789938B (en) Conveyor belt assembly for packaging of containers for medical use
JP4329066B2 (en) Sterility test sampling method and apparatus
IT201800004068A1 (en) MACHINE FOR FILLING AND CLOSING PHARMACEUTICAL CONTAINERS, SUCH AS SYRINGES, BOTTLES AND SIMILAR
EP3976477B1 (en) Equipment for packaging products, and in particular for re-packaging products that have already been previously packaged
KR20250069595A (en) Method for sterilizing components of a machine that operates in a sterile closed environment and that is used for contact with products that are to be processed inside the closed environment

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190227

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210104

INTG Intention to grant announced

Effective date: 20210113

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1374271

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210415

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017035230

Country of ref document: DE

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210624

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210624

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210625

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20210324

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1374271

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2874645

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20211105

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210726

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210724

REG Reference to a national code

Ref country code: DE

Ref legal event code: R026

Ref document number: 602017035230

Country of ref document: DE

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: BAUSCH + STROEBEL MASCHINENFABRIK ILSHOFEN GMBH + CO. KG

Effective date: 20211223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210731

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210724

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210726

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210726

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210731

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230426

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20170726

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: BAUSCH + STROEBEL MASCHINENFABRIK ILSHOFEN GMBH + CO. KG

Effective date: 20211223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

PUAH Patent maintained in amended form

Free format text: ORIGINAL CODE: 0009272

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: PATENT MAINTAINED AS AMENDED

27A Patent maintained in amended form

Effective date: 20250910

AK Designated contracting states

Kind code of ref document: B2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R102

Ref document number: 602017035230

Country of ref document: DE

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20250827

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20250723

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20250722

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20250724

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20250717

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20250801

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210324

REG Reference to a national code

Ref country code: ES

Ref legal event code: DC2A

Ref document number: 2874645

Country of ref document: ES

Kind code of ref document: T5

Effective date: 20260102